Diabetes Self-Management Articles

These articles cover a wide range of subjects, from the most basic aspects of diabetes care to the nitty-gritty specifics.

Links not loading properly?

Some of our pages use Portable Document Format (PDF) files, which require Adobe Acrobat Reader. To download Acrobat Reader for free, visit www.adobe.com.

Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.

Learn more

Learn more about diabetes

Links to help you learn more about diabetes.

Ask a diabetes expert
Other diabetes resources
Browse article topics


Protecting Your Kidneys

by Robert S. Dinsmoor

In some cases, initial therapy for high blood pressure should consist of lifestyle modifications, such as losing weight, cutting back on sodium and alcohol consumption, and getting more exercise. One of the most effective lifestyle changes would be to follow the DASH (Dietary Approaches to Stop Hypertension) eating plan, which is a diet low in saturated fat, total fat, and cholesterol that emphasizes fruits, vegetables, and low-fat dairy products. The DASH diet is most effective when combined with a reduction in sodium intake. You can download a copy of “Facts About the DASH Eating Plan” that includes a week’s worth of menus from www.nhlbi.nih.gov/health/public/heart/hbp/dash or call (301) 592-8573 for a free copy.

For treating high blood pressure in people with diabetes — or for treating anyone with diabetes and microalbuminuria or overt nephropathy — specific blood-pressure-lowering drugs called angiotensin-converting enzyme (ACE) inhibitors and angiotensin- II receptor blockers (ARBs) are the drugs of choice. ACE inhibitors include quinapril (Accupril), perindopril (Aceon), ramipril (Altace), captopril (Capoten), benazepril (Lotensin), trandolapril (Mavik), fosinopril (Monopril), lisinopril (Prinivil, Zestril), moexipriol (Univasc), and enalapril (Vasotec). ARBs include candesartan (Atacand), irbesartan (Avapro), olmesartan (Benicar), losartan (Cozaar), valsartan (Diovan), telmisartan (Micardis), and eprosartan (Teveten). These drugs appear to have a protective effect on kidneys above and beyond blood pressure control.

ACE normally converts a hormone called angiotensin I to a related hormone called angiotensin II, which constricts blood vessels, increases sodium and water retention, activates the sympathetic nervous system, stimulates fibrosis (stiffening) of the heart and blood vessels, and promotes heart cell growth. The immediate net effect of these changes is to raise blood pressure, but over time this hormone can cause damage to the heart and kidneys. ACE inhibitors block the action of ACE, thus decreasing the amount of angiotensin II and in turn minimizing its effects.

ARBs also work to decrease the effects of angiotensin II, but at a different point in the process. For angiotensin II to exert its effects throughout the body, it must bind to certain receptors (much as a key fits into a lock) on cell surfaces. ARBs prevent angiotensin II from binding to its receptors and thus reduce its effects.

Large numbers of studies have shown that in people with diabetes, ACE inhibitors can have a number of beneficial effects, including preventing or delaying the progression of nephropathy in people with microalbuminuria or overt diabetic nephropathy, decreasing the risk of heart attack and stroke, and decreasing mortality, so people with diabetes and hypertension are routinely prescribed ACE inhibitors.

Like ACE inhibitors, ARBs decrease levels of albumin in the urine and have been shown to effectively prevent progression of nephropathy in people with microalbuminuria or overt diabetic nephropathy. If an ACE inhibitor or ARB used alone is not sufficient to lower blood pressure, other blood-pressure-lowering drugs such as diuretics may need to be added; ACE inhibitors and ARBs can even be used together. (Read “Analgesics and Kidney Health” for information on how various over-the-counter medicines affect the kidneys.)

The effectiveness of dietary protein restriction in protecting the kidneys remains somewhat controversial. Dietary protein restriction has been shown to slow the progression of kidney disease in some animal models. Small clinical studies in people with diabetic kidney disease have shown that people who were able to restrict their dietary protein to 0.8 grams per kilogram of body weight per day (which is actually also the Recommended Dietary Allowance of protein for adults) were able to modestly slow the rate of fall in GFR. That level of protein consumption works out to about 54 grams of protein per day for a person weighing 150 pounds.

Page    1    2    3    4    5    Show All    

Also in this article:
Analgesics and Kidney Health
The Function of a Kidney



More articles on Diabetic Complications



Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information provided on this Web site should not be construed as medical instruction. Consult appropriate health-care professionals before taking action based on this information.



Reducing Diabetes Risks for the Whole Family
Diabetes is a disease that affects more and more Americans every day: Almost 26 million children... Article

What Is Your Urine Trying to Tell You?
I realize that it may seem strange to be reading a posting about urine. However, last week... Blog

Understanding Your Lab Test Results
Diabetes is a chronic condition that requires an enormous amount of self-care and that can... Article

How much should I eat while I'm pregnant? Get tip

Carbohydrate Restriction: An Option for Diabetes Management
Some people find that decreasing the amount of carbohydrate they eat can help with blood glucose control. Here’s what to know about this approach.

Insulin Patch Pumps: A New Tool for Type 2
Patch pumps are simpler to operate than traditional insulin pumps and may be a good option for some people with Type 2 diabetes who need insulin.

How Much Do You Know About Vitamins?
Learn what these micronutrients can and can’t do for you.

Complete table of contents
Subscription questions